Collagen Peptide Supplements Reduce Exercise-Related Knee Pain in Young Active Adults

Taking 5 grams of specific collagen peptides daily for 12 weeks significantly reduced exercise-induced knee pain in 180 young adults compared to placebo.

Zdzieblik, Denise et al.·Nutrients·2021·
RPEP-059212021RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Participants taking collagen peptides experienced a 21.9 mm reduction on the Visual Analog Scale (VAS) for exercise-induced knee pain, compared to 15.6 mm for placebo (p = 0.024). Physician evaluations showed an even clearer difference: 23.0 mm reduction versus 14.6 mm (p = 0.003).

Pain at rest and after performing 20 squats did not differ significantly between groups, but this was largely because few participants had pain under those conditions at baseline. Joint mobility was clinically unremarkable at the start and remained unchanged.

Key Numbers

How They Did This

This was a randomized, double-blind, placebo-controlled trial. 180 physically active men and women aged 18–30 with exercise-related knee pain but no diagnosed joint disease were randomly assigned to receive either 5 grams of specific type I collagen peptides (mean molecular weight 3 kDa) or placebo daily for 12 weeks. Pain was measured using the Visual Analog Scale (VAS) both by participants and examining physicians. Secondary outcomes included pain at rest, pain after squats, knee mobility, and use of alternative therapies.

Why This Research Matters

Exercise-related joint discomfort is extremely common in active young adults, yet most joint health research focuses on older populations with arthritis. This confirmatory trial shows that a simple, affordable collagen peptide supplement can meaningfully reduce activity-related knee pain in otherwise healthy young people — a population that typically has few options beyond rest and anti-inflammatory drugs.

The Bigger Picture

Collagen peptide supplementation has gained significant commercial popularity, but clinical evidence has been mixed. This study is notable because it was designed as a confirmatory trial — replicating earlier positive findings in a similar population. Successful replication strengthens the case that these specific collagen peptides have a real, if modest, effect on exercise-related joint pain in young adults.

What This Study Doesn't Tell Us

The pain reduction, while statistically significant, was modest in absolute terms (about 6 mm difference on a 100 mm VAS scale). The study was funded by a collagen peptide manufacturer (GELITA AG), and one author is a company employee. The 12-week duration doesn't reveal whether benefits persist long-term. Only activity-related pain was significantly affected — resting pain and joint mobility showed no benefit.

Questions This Raises

  • ?Would the benefits persist beyond 12 weeks or increase with longer supplementation?
  • ?Do these collagen peptides actually improve cartilage structure, or do they primarily reduce pain perception?
  • ?Would higher doses produce a larger effect, or is 5 grams the optimal amount?

Trust & Context

Key Stat:
21.9 mm pain reduction Collagen peptide group saw significantly greater reduction in exercise-induced knee pain on the VAS scale compared to 15.6 mm for placebo
Evidence Grade:
This is a well-designed randomized, double-blind, placebo-controlled trial with 180 participants — a decent sample size for a supplement study. It was specifically designed to confirm earlier positive findings, adding replication value. However, industry funding and modest effect sizes warrant some caution.
Study Age:
Published in 2021 in Nutrients. The findings remain relevant as collagen peptide supplementation continues to be widely marketed and used.
Original Title:
The Influence of Specific Bioactive Collagen Peptides on Knee Joint Discomfort in Young Physically Active Adults: A Randomized Controlled Trial.
Published In:
Nutrients, 13(2) (2021)
Database ID:
RPEP-05921

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

How much collagen did participants take daily?

Participants took 5 grams per day of specific type I collagen peptides with a mean molecular weight of 3 kDa. This is a standard supplementation dose and was taken daily for 12 weeks.

Did collagen peptides help with knee pain at rest?

No. The significant benefit was only for exercise-induced pain. Pain at rest and after performing squats didn't differ between groups, largely because most participants only experienced pain during sustained physical activity.

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-05921·https://rethinkpeptides.com/research/RPEP-05921

APA

Zdzieblik, Denise; Brame, Judith; Oesser, Steffen; Gollhofer, Albert; König, Daniel. (2021). The Influence of Specific Bioactive Collagen Peptides on Knee Joint Discomfort in Young Physically Active Adults: A Randomized Controlled Trial.. Nutrients, 13(2). https://doi.org/10.3390/nu13020523

MLA

Zdzieblik, Denise, et al. "The Influence of Specific Bioactive Collagen Peptides on Knee Joint Discomfort in Young Physically Active Adults: A Randomized Controlled Trial.." Nutrients, 2021. https://doi.org/10.3390/nu13020523

RethinkPeptides

RethinkPeptides Research Database. "The Influence of Specific Bioactive Collagen Peptides on Kne..." RPEP-05921. Retrieved from https://rethinkpeptides.com/research/zdzieblik-2021-the-influence-of-specific-2

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.